Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Research Area(s) / Expertise: Job title: Director, Cardiac Cath Lab and Interventional Cardiology Unit
Personal History Dr Colombo was born in Busto Arsizio, Italy on June 17, 1950.7 After completing his schooling in Gallarate, he went on to the University of Milan School of Medicine in 1968, before attending the University of Parma Postgraduate School to study Cardiovascular Medicine. From a young age, he was a gifted student; and ultimately graduated Summa Cum Laude from his medical school.7 … View more
TAVI for Pure Aortic Regurgitation With Dedicated Devices
Author(s): Pierluigi Costanzo , Paul Bamborough , Mark Peterson , et al Added: 1 year ago

Imaging & Diagnostics

Intervention
Author(s): Neil Ruparelia Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is now the accepted treatment option of choice for patients presenting with severe symptomatic aortic stenosis who are deemed to be inoperable or of high surgical risk.1,2 Short- and intermediate-term outcomes have been promising3–5 and with increasing institutional and operator experience combined with technological advancements there has been… View more

Prevention & Chronic Conditions

Intervention
Author(s): Maurizio Taramasso , Christelle Calen , Andrea Guidotti , et al Added: 3 years ago
The leading aetiology of tricuspid regurgitation (TR) in developed countries is functional, secondary to left side heart disease and pulmonary hypertension.1 Currently, moderate-to-severe TR affects approximately 1.6 million patients in the United States, of whom only 8,000 undergo tricuspid surgery annually;2 this results in an extremely large number of untreated patients with significant TR, a… View more

Intervention
Eugene Braunwald
Research Area(s) / Expertise:

Cardiomyopathy

Heart Failure

 Job title: Distinguished Hersey Professor of Medicine, MACC
Personal History Dr Braunwald is an Austrian-born American cardiologist. He was born on August 15, 1929 to Jewish parents and moved to the United States in 1939.1, 3 “I had an idyllic childhood there with an excellent school and tutors in English and piano,” he says.6 He has a younger brother who became a haematologist.1 Music is one of Dr Braunwald’s passions. He is also a keen traveler:… View more
Broadening TEER Options for Your Patients
Author(s): Philipp Lurz , Georg Nickenig , Nina Wunderlich , et al Added: 11 months ago
Mitral and tricuspid regurgitation can now be safely and effectively treated using transcatheter edge-to-edge repair (TEER). ThePASCAL Precision systemoffers a differentiated platform to significantly reduce mitral or tricuspid regurgitation and improve your patients’ outcomes. This recording of the live broadcast allows you to appreciate the key features and applications of thePASCAL… View more

Intervention
Author(s): Hellmuth Weich Added: 3 years ago
There has been a recent explosion in the field of transcatheter aortic and pulmonary valve replacements, but the atrio-ventricular valves have lagged behind for various reasons with the tricuspid valve undoubtedly the least treated valve of the four. Despite the fact that tricuspid regurgitation (TR) can result in significant symptoms, patients are rarely referred for isolated surgical tricuspid… View more

Vascular Disease and Surgery

Intervention
Anti-thrombotic Therapy Following TAVI: UK and Ireland Consensus Statement
Author(s): Azfar Zaman , Bernard Prendergast , David Hildick-Smith , et al Added: 1 year ago

Anticoagulation
Author(s): Pascal Thériault-Lauzier , Marco Spaziano , Beatriz Vaquerizo , et al Added: 3 years ago
Valvular Disease Aortic valve Severe symptomatic aortic stenosis (AS) bears a dismal prognosis. The mean survival is 2.0 to 4.7 years after the onset of angina, 0.8 to 3.8 years after the onset of syncope and 0.5 to 2.8 years after the onset of congestive heart failure.1 Surgical aortic valve replacement (SAVR) is the mainstay of treatment for these patients.2 In the last decade transcatheter… View more

Vascular Disease and Surgery

Imaging & Diagnostics
Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
Author(s): Antonio Greco , Davide Capodanno Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is a valuable treatment option for patients with severe symptomatic aortic stenosis.1 Its use is supported by the results of multiple randomised controlled trials (RCTs) exploring the entire surgical risk spectrum, including inoperable, high-risk, intermediate risk and low risk patients.2–8 TAVI is associated with a small but not negligible… View more

Vascular Disease and Surgery

Intervention